65 related articles for article (PubMed ID: 18088232)
1. Stat5 as a diagnostic marker for leukemia.
Lewis RS; Ward AC
Expert Rev Mol Diagn; 2008 Jan; 8(1):73-82. PubMed ID: 18088232
[TBL] [Abstract][Full Text] [Related]
2. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
Himpe E; Kooijman R
Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma.
Martini M; Hohaus S; Petrucci G; Cenci T; Pierconti F; Massini G; Teofili L; Leone G; Larocca LM
Am J Clin Pathol; 2008 Mar; 129(3):472-7. PubMed ID: 18285272
[TBL] [Abstract][Full Text] [Related]
5. Going with the flow: JAK-STAT signaling in JMML.
Kalaitzidis D; Gilliland DG
Cancer Cell; 2008 Oct; 14(4):279-80. PubMed ID: 18835028
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma.
Fantin VR; Loboda A; Paweletz CP; Hendrickson RC; Pierce JW; Roth JA; Li L; Gooden F; Korenchuk S; Hou XS; Harrington EA; Randolph S; Reilly JF; Ware CM; Kadin ME; Frankel SR; Richon VM
Cancer Res; 2008 May; 68(10):3785-94. PubMed ID: 18483262
[TBL] [Abstract][Full Text] [Related]
7. STAT5 and STAT5 Inhibitors in Hematological Malignancies.
Tolomeo M; Meli M; Grimaudo S
Anticancer Agents Med Chem; 2019; 19(17):2036-2046. PubMed ID: 31490767
[TBL] [Abstract][Full Text] [Related]
8. Physical and functional interactions between STAT5 and Runx transcription factors.
Ogawa S; Satake M; Ikuta K
J Biochem; 2008 May; 143(5):695-709. PubMed ID: 18296717
[TBL] [Abstract][Full Text] [Related]
9. Gene expression analysis of BCR/ABL1-dependent transcriptional response reveals enrichment for genes involved in negative feedback regulation.
Håkansson P; Nilsson B; Andersson A; Lassen C; Gullberg U; Fioretos T
Genes Chromosomes Cancer; 2008 Apr; 47(4):267-75. PubMed ID: 18181176
[TBL] [Abstract][Full Text] [Related]
10. The SPS affair: a complex tale of illicit proliferation.
Braun BS; Shannon K
Cancer Cell; 2009 Aug; 16(2):87-8. PubMed ID: 19647218
[TBL] [Abstract][Full Text] [Related]
11. FAK silencing inhibits leukemogenesis in BCR/ABL-transformed hematopoietic cells.
Le Y; Xu L; Lu J; Fang J; Nardi V; Chai L; Silberstein LE
Am J Hematol; 2009 May; 84(5):273-8. PubMed ID: 19358301
[TBL] [Abstract][Full Text] [Related]
12. Suppressors of cytokine signaling as tumor repressors. Silencing of SOCS3 facilitates tumor formation and growth in lung and liver.
Baltayiannis G; Baltayiannis N; Tsianos EV
J BUON; 2008; 13(2):263-5. PubMed ID: 18555475
[TBL] [Abstract][Full Text] [Related]
13. Activation of the mouse TCRgamma enhancers by STAT5.
Tani-ichi S; Satake M; Ikuta K
Int Immunol; 2009 Sep; 21(9):1079-88. PubMed ID: 19651644
[TBL] [Abstract][Full Text] [Related]
14. Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice.
Mizuno T; Yamasaki N; Miyazaki K; Tazaki T; Koller R; Oda H; Honda ZI; Ochi M; Wolff L; Honda H
Oncogene; 2008 May; 27(24):3465-74. PubMed ID: 18193087
[TBL] [Abstract][Full Text] [Related]
15. MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells.
Nishioka C; Ikezoe T; Yang J; Takeuchi S; Koeffler HP; Yokoyama A
Leuk Res; 2008 Sep; 32(9):1382-92. PubMed ID: 18394702
[TBL] [Abstract][Full Text] [Related]
16. Signaling networks regulating cardiac myocyte survival and death.
Wagner M; Siddiqui MA
Curr Opin Investig Drugs; 2009 Sep; 10(9):928-37. PubMed ID: 19705335
[TBL] [Abstract][Full Text] [Related]
17. The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy.
Tao W; Wen F; Zhang H; Liu G
Brain Dev; 2009 Mar; 31(3):200-7. PubMed ID: 18715729
[TBL] [Abstract][Full Text] [Related]
18. IFNgamma signaling-does it mean JAK-STAT?
Gough DJ; Levy DE; Johnstone RW; Clarke CJ
Cytokine Growth Factor Rev; 2008; 19(5-6):383-94. PubMed ID: 18929502
[TBL] [Abstract][Full Text] [Related]
19. Polysaccharopeptide mimics ciclosporin-mediated Th1/Th2 cytokine balance for suppression of activated human T cell proliferation by MAPKp38 and STAT5 pathways.
Lee CL; Sit WH; Jiang PP; So IW; Wan JM
J Pharm Pharmacol; 2008 Nov; 60(11):1491-9. PubMed ID: 18957170
[TBL] [Abstract][Full Text] [Related]
20. A role of Gab2 association in Flt3 ITD mediated Stat5 phosphorylation and cell survival.
Masson K; Liu T; Khan R; Sun J; Rönnstrand L
Br J Haematol; 2009 Jul; 146(2):193-202. PubMed ID: 19438505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
